Drugs@FDA application timeline
BLA208471
7 dated FDA-coded AP submissions from 2016-07-27 through 2026-03-12, connected to 7 source-defined action assignments and 16 official document links.
7Dated AP submissions
7Action assignments
16Official documents
0Exact enforcement reports
1Reviewed profile mappings
Reviewed identity mapping
Connected peptide profiles
Newest first
Submission and document chronology
7 submissions2026-03-12 · status AP
Supplement 12
FDA action labels
Labeling-Package Insert
3 official documents
2025-05-28 · status AP
Supplement 10
FDA action labels
Labeling-Package Insert
2 official documents
- Label ↗2025-06-02 · FDA document 82390
- Letter ↗2025-05-29 · FDA document 82346
2024-11-01 · status AP
Supplement 9
FDA action labels
Labeling-Package Insert
2 official documents
- Letter ↗2024-11-05 · FDA document 80123
- Label ↗2024-11-04 · FDA document 80113
2023-09-28 · status AP
Supplement 7
FDA action labels
Labeling-Package Insert
2 official documents
- Letter ↗2023-09-29 · FDA document 75623
- Label ↗2023-09-29 · FDA document 75612
2022-06-10 · status AP
Supplement 5
FDA action labels
Labeling-Package Insert · Labeling-Patient Package Insert
2 official documents
- Label ↗2022-06-15 · FDA document 71308
- Letter ↗2022-06-13 · FDA document 71275
2021-07-30 · status AP
Supplement 4
FDA action labels
Efficacy-Labeling Change With Clinical Data
2 official documents
- Label ↗2021-08-03 · FDA document 68270
- Letter ↗2021-08-02 · FDA document 68246
2016-07-27 · status AP
Original submission 1
No source action-type assignment was retained for this submission.
3 official documents
- Review ↗2020-03-23 · FDA document 45985
- Label ↗2020-03-23 · FDA document 40635
- Letter ↗2020-03-23 · FDA document 32910
Source archive dated 2026-08-24; observed 2026-08-24T21:23:49.000Z; reviewed 2026-08-24. Observation SHA-256: 6166fd223ef126a19e8ebfdaafe1fbf7c330a4cf7153cef00fb6c52c45ef757b.